| Style | Citing Format |
|---|---|
| MLA | Mohammadi M, et al.. "A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo." Frontiers in Immunology, vol. 11, no. , 2021, pp. -. |
| APA | Mohammadi M, Jedditehrani M, Golsazshirazi F, Arjmand M, Bahadori T, Judaki MA, Shiravi F, Zare HA, Haghighat FN, Mobini M, Amiri MM, Shokri F (2021). A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo. Frontiers in Immunology, 11(), -. |
| Chicago | Mohammadi M, Jedditehrani M, Golsazshirazi F, Arjmand M, Bahadori T, Judaki MA, Shiravi F, et al.. "A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo." Frontiers in Immunology 11, no. (2021): -. |
| Harvard | Mohammadi M et al. (2021) 'A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo', Frontiers in Immunology, 11(), pp. -. |
| Vancouver | Mohammadi M, Jedditehrani M, Golsazshirazi F, Arjmand M, Bahadori T, Judaki MA, et al.. A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo. Frontiers in Immunology. 2021;11():-. |
| BibTex | @article{ author = {Mohammadi M and Jedditehrani M and Golsazshirazi F and Arjmand M and Bahadori T and Judaki MA and Shiravi F and Zare HA and Haghighat FN and Mobini M and Amiri MM and Shokri F}, title = {A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo}, journal = {Frontiers in Immunology}, volume = {11}, number = {}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Mohammadi M AU - Jedditehrani M AU - Golsazshirazi F AU - Arjmand M AU - Bahadori T AU - Judaki MA AU - Shiravi F AU - Zare HA AU - Haghighat FN AU - Mobini M AU - Amiri MM AU - Shokri F TI - A Novel Anti-Her2 Bispecific Antibody With Potent Tumor Inhibitory Effects in Vitro and in Vivo JO - Frontiers in Immunology VL - 11 IS - SP - EP - PY - 2021 ER - |